Generics have become available in increasingly short supply as manufacturers chase profits on higher-priced medications rather than production on generic versions.
In an effort to counteract the rising prices and shortages of generic drugs, Civica Rx and Xellia Pharmaceuticals have teamed up to produce the antibiotics vancomycin and daptomycin for Civica's members.
Modern Healthcare reports that those antibiotics, used to treat critically ill patients with infections resistant to other antibiotics, are the first on Civica's list of 14 generic medications the partnership plans to produce this year.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Marlene Satter
Marlene Y. Satter has worked in and written about the financial industry for decades.
